Welcome to our dedicated page for CAVCO INDUSTRIES SEC filings (Ticker: CVCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cavco Industries filings document material events for a Nasdaq-listed Delaware company with common stock trading under CVCO. Recent 8-K reports cover fiscal operating results, results-of-operations disclosures and press-release exhibits tied to the company’s factory-built housing and financial services businesses.
The filing record also documents governance and capital-structure matters, including board composition changes, committee appointments, director compensation and indemnification arrangements. Acquisition-related 8-K disclosures record the completed American Homestar transaction, including the surviving subsidiary structure, cash consideration mechanics, regulatory clearance and related material agreement terms.
Seth G. Schuknecht, Executive Vice President and General Counsel of Cavco Industries, reported a sale of 145 shares of Cavco common stock on 09/04/2025 at a price of $550 per share. The filing states the sale occurred automatically under a Rule 10b5-1 trading plan adopted December 5, 2024, and that this transaction completes that plan. After the reported sale, the reporting person beneficially owns 1,133 shares, which include 1,068 shares underlying restricted stock units that are allocated but not yet vested or delivered. The Form 4 is signed by the reporting person on 09/08/2025.
Cavco Industries, Inc. (CVCO) filed a Form 144 reporting a proposed sale of 145 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $77,372. The shares were acquired as restricted stock units on 02/13/2025 and the filing lists an approximate sale date of 09/04/2025 on NASDAQ. The filer reports no securities sold in the past three months and makes the required representation that they are not aware of undisclosed material adverse information about the issuer.
Paul Bigbee, Chief Accounting Officer of Cavco Industries, reported a sale of 300 shares of Cavco common stock on 08/29/2025 at a reported price of $530.45 per share. After the transaction he is shown as beneficially owning 774 shares directly. The filing also notes 461 restricted stock units allocated but not yet vested or delivered. The Form 4 was filed as a single reporting person submission and bears a signature filed by an attorney-in-fact on 09/02/2025. The report documents an insider disposition and the remaining direct holdings and unvested awards held by the reporting person.
Brian R. Cira, President, Manufactured Housing at Cavco Industries (CVCO), reported two related transactions on 08/25/2025. He acquired 1,000 shares at a reported price of $153.94 and sold 1,000 shares at $522 on the same date. Following these transactions he beneficially owned 3,081 shares, which includes 699 restricted stock units that are allocated but not yet vested or delivered. The filing also discloses a non-qualified stock option tied to 1,000 shares with a $153.94 exercise price that was exercisable and became fully exercisable earlier and expires on July 9, 2026. The form was signed by an attorney-in-fact on 08/27/2025.
Susan L. Blount, a director of Cavco Industries, executed option and sale transactions on August 22, 2025. She exercised 2,500 non-employee director stock options at an exercise price of $141.16 per share, receiving 2,500 common shares. On the same date she sold a total of 2,500 common shares in multiple trades: 411 shares at a volume-weighted average price of $518.24 and 2,089 shares at a volume-weighted average price of $519.51. After these transactions she beneficially owns 3,126 shares, which include 290 restricted stock unit shares allocated but not yet vested. The exercised options became fully exercisable on January 8, 2023 and expire January 8, 2026.
Cavco Industries (CVCO) insider sale disclosed on Form 4. Paul Bigbee, the company's Chief Accounting Officer and a director, reported selling 300 shares of Cavco common stock on 08/22/2025 at a reported price of $522.68 per share. Following the sale he beneficially owns 1,074 shares, which includes 461 restricted stock units that are allocated but not yet vested or delivered. The filing was signed by an attorney-in-fact on 08/26/2025. The form shows a single non-derivative disposition and no derivative transactions.
Form 144 notice for proposed sale of securities. The filing reports an intended sale of 1,000 shares of common stock through Morgan Stanley Smith Barney LLC on 08/25/2025 on NASDAQ with an aggregate market value of $522,000 and 7,917,647 shares outstanding. The shares were acquired on 08/25/2025 by stock option exercise from the issuer, paid in cash. The filer reports no securities sold in the past three months and includes the standard representation that no undisclosed material adverse information is known.
Kerley Richard A, a director of Cavco Industries, Inc. (CVCO), reported a sale of company common stock on 08/20/2025. The filing shows 500 shares were disposed of at a price of $480.55 per share, leaving the reporting person with 7,169 shares reported as beneficially owned indirectly through the Kerley Family Trust. The filing also discloses 290 shares underlying restricted stock units that are allocated but not yet vested or delivered. The Form 4 was signed by an attorney-in-fact on 08/22/2025.
Cavco Industries insider sale notice: 2,500 shares to be sold on 08/22/2025 via Morgan Stanley, representing an aggregate market value of $1,298,259. The form states the securities were acquired the same day by stock option exercise and paid in cash. The filer previously sold 2,000 shares on 08/14/2025 for gross proceeds of $481,946.80 and $485,000.00 in two transactions. The notice includes the seller's representation that they are not aware of undisclosed material adverse information about the issuer.
Cavco Industries (CVCO) Form 144 reports a proposed sale of 500 common shares through Charles Schwab, scheduled approximately 08/20/2025. The filing shows an aggregate market value of $242,525 and indicates 7,917,647 shares outstanding for the class. The 500 shares were acquired as vested restricted stock awards: 200 shares on 07/09/2020 and 300 shares on 07/28/2021, with payment characterized as equity compensation. The filer states no securities were sold in the past three months and affirms absence of undisclosed material adverse information.